After-Hours Stock Movers 10/25: (ANAB) (GERN) (FB) Higher; (VTNR) (CLAR) (UHS) Lower (more...)

October 25, 2021 5:39 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

After-Hours Stock Movers:

Vertex Energy, Inc. (NASDAQ: VTNR) 15.6% LOWER; announced its intention to offer, subject to market conditions and other factors, $155 million aggregate principal amount at maturity of its convertible senior notes due 2027 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers and/or to "accredited investors" in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act").

AnaptysBio, Inc. (Nasdaq: ANAB) 12.2% HIGHER; announced the signing of an agreement with Sagard Healthcare Royalty Partners to monetize a portion of AnaptysBios future JEMPERLI royalties and milestones. AnaptysBio intends to utilize the proceeds of the transaction towards funding of its wholly-owned preclinical and clinical-stage antibody programs.

Geron Corporation (Nasdaq: GERN) 8.2% HIGHER; announced that imetelstat, the Companys first in class telomerase inhibitor, has been granted an Innovation Passport, which is the first prescribed entry point to the Innovative Licensing and Access Pathway (ILAP) launched in the United Kingdom (UK) by the Medicines and Healthcare products Regulatory Agency (MHRA) in January 2021, post-Brexit. The objective of this new licensing and access pathway is to reduce the time to market for innovative medicines. Key benefits of being within ILAP include a 150-day accelerated assessment and rolling review of a Marketing Authorization Application (MAA), as well as opportunities for frequent interactions with the review staff at the MHRA and its partner agencies, including the National Institute for Health and Care Excellence (NICE), to discuss imetelstats development, regulatory plans and reimbursement plans.

Clarus Corporation (NASDAQ: CLAR) 5.8% LOWER; intends to offer, subject to market and other conditions, 2,750,000 shares of common stock registered under the Securities Act of 1933, as amended. The Company also expects to grant to the underwriters an option for 30 days to purchase up to an additional 412,500 shares of common stock.

Universal Health (NYSE: UHS) 3% LOWER; reported Q3 EPS of $2.67, $0.07 worse than the analyst estimate of $2.74. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3.1 billion.

Facebook (NASDAQ: FB) 2.3% HIGHER; reported Q3 EPS of $3.22, $0.03 better than the analyst estimate of $3.19. Revenue for the quarter came in at $29.01 billion versus the consensus estimate of $29.58 billion. Facebook sees Q4 revenue of $31.5 to $34 billion vs consensus of $34.89 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers